HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
Home » News » German Drug Assessment Watchdog Pushes Direct Comparison of Cancer Immunotherapies

German Drug Assessment Watchdog Pushes Direct Comparison of Cancer Immunotherapies

IQWiG, and independent drug assessment body in Germany, is pushing for direct comparison data in a new class of cancer immunotherapies.

The move comes as the watchdog speaks out against what it says is a lack of data in the class of immunotherapies, suggesting physicians could be either overwhelmed or misled by available data, according to a Reuters report.

IQWiG says patients unaffected by previous rounds of standard chemotherapy could see potential benefits from Keytruda (Merck & Co) and Tecentriq (Roche), but that head-to-head drug trials are necessary for physicians to select the better treatment option.

“The procedure of the early benefit assessment does unfortunately not allow a comparison of new drugs against each other,” Juergen Windeler, IQWiG’s director, said in a statement. “Such a measure appears to be almost indispensable in the case of urothelial (bladder) carcinoma: We now have three drugs for the same therapeutic indication, but are unable to reasonably relate the assessment results to each other.”

To read more about the watchdog’s push on Reuters.



You might also be interested in:

  • Telehealth Could Advance Value-based Care in the US 12/15/2021
  • Despite WHO Recommendation, COVID-19 Drug Too Costly and… 07/12/2021
  • Navigating the CURES Act and Patient Access Final Rules: 7 Key… 12/01/2021
  • Exploring Climate Change Through the Lens of Health Equity 05/25/2022
  • OM1 Launches Real-World Data Network for Neuroscience and… 03/31/2022
  • FDA Will Present Draft Guidance on Real-World Evidence in… 06/22/2022
  • Independent Medical Education & Grants Summit | September… 06/09/2022

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Manager, Statistical Analytics
  • Director / Senior Director, RWE
  • Research Analyst
  • Medical Writer
  • Associate Director/Director, Business Development
 
Syndicated Reports

Economic & Related Consulting Service Revenues World Report & Database

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 – Key Players are Eurofins Scientific, SGS S.A., Charles River Laboratories

Risk-Based Monitoring Software Market Worth $511 Million By 2025 – Growing Number Of Clinical Trials To Propel Market Growth

Real-World Evidence Solutions Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)

 
White Papers

The Augmented Rep: A practical field force guide for the Omnichannel era

Rare Disease’s Star Turn

The Next Generation of Information Management

Risk Mitigation for Pharma Manufacturer Programs

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts